Axon Enterprise, Inc.
AXON - NASDAQ - $403.54 ▼ -%5.47
-
Earnings Mon 3 Aug

Axon opens the
books on Monday evening.

10 analysts' median target is $690[FMP target], stock is $404, +71.0% upside potential. After Q1 +0.6% EPS beat[FMP earnings], the stock moved +10.6%.

summary below
Quick Take - in 40 seconds
B-
BUY Council 3/6 - Moonshot 50

B- = MoonshotScore 50[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $876.1M[FMP est], EPS $1.86[FMP est]. 2 consecutive quarters of beat[FMP earnings].

$1.86 EPS Estimate Last year $1.61 - -12% YoY YoY
2 Beat Streak Expectations beaten consecutively for the last 2 quarters

Q1 EPS +0.6% beat[FMP] but the stock +10.6% D+1[FMP D+1]. Brittany Bagley promised $23.1M CapEx + a sequential decline in Q1 during the Q1 earnings call[Brittany Bagley capex transcript].

Watchlist

6 metrics stand out this quarter.

%30 Expectation / Guide

Fy26 Revenue Guidance

fy26_revenue_guidance

The company is raising its revenue guidance for 2026 to a range of 30% to 32% growth, driven by strong Q1 results and momentum in the pipeline.

"Given these trends, our strong Q1 results and the momentum we are seeing in our pipeline, we're well positioned to deliver on our top line expectations and are raising our revenue guidance for the year to a range of 30% to 32% growth."

- Brittany Bagley - Q1 FY26 Earnings Call - May 6, 2026
%100 Investor Focus

International Growth

international_growth

International revenue was up over 100% year-over-year and represented 20% of revenue for the quarter.

"International revenue was up over 100% year-over-year as we delivered on the bookings momentum we highlighted last year and it represented 20% of our revenue for the quarter."

- Brittany Bagley - Q1 FY26 Earnings Call - May 6, 2026
$450 million Expectation / Guide

Free Cash Flow Guidance

free_cash_flow_guidance

The company expects to deliver approximately $450 million of free cash flow full year in 2026, even with continued investments in inventory.

"Even with these investments, we expect free cash flow conversion to improve meaningfully and expect to deliver approximately $450 million of free cash flow full year in 2026."

- Brittany Bagley - Q1 FY26 Earnings Call - May 6, 2026
%500 Investor Focus

Dedrone Growth

dedrone_growth

Dedrone's growth is exceeding aggressive assumptions, with rising demand seen across all markets.

"Dedrone, our counter drone business is scaling beyond our most aggressive assumptions. Bookings are up 500% year-over-year, and we are continuing to see rising demand."

- Joshua Isner - Q1 FY26 Earnings Call - May 6, 2026
%140 Investor Focus

Ai Era Plan Adoption

ai_era_plan_adoption

Adoption of the AI Era Plan is rapidly increasing, with large-scale agencies viewing AI as a core capability.

"AI bookings were up 140% versus Q1 last year and we are seeing AI move from early interest to a standard part of how large agencies think about their future technology stack."

- Joshua Isner - Q1 FY26 Earnings Call - May 6, 2026
%50 Investor Focus

Enterprise Expansion

enterprise_expansion

Axon closed a $40 million deal with a major telecom provider using Fusus, continuing its expansion in the enterprise market.

"After a 50% year-over-year Q1 in April, our team closed a $40 million opportunity with one of the largest telecom providers in the world. The deployment centers around Fusus, which continues to garner interest and drive growth in this segment, along with Axon Body Mini and Axon Outpost."

- Joshua Isner - Q1 FY26 Earnings Call - May 6, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Klarman, Munger), 1 bearish (Ken Griffin), 2 neutral (Jim Simons, Buffett).

How is it calculated? ->
Ray Dalio macro - target upside +71.0%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 48
Klarman value - target upside +71.0%
Buffett quality - ROE score 3/5
Munger valuation - target upside +71.0%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthWeak
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCTight
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
48.2 RSI 48.2 balanced, 50d below
MACD
-9.60 price below 50d - resistance dominant
50d MA
$446 stock 9.6% below - short-term resistance
200d MA
$593 stock 31.9% below - long-term pressure
Volume (10d)
+33% increase - pre-earnings positioning
Resistance
$690
Analyst median target - upgrade trigger if broken
Current
$404
Pre-earnings position
Support
$504
Invalidation - close below this is a technical breakdown
Pattern
Range
$504-$690 band - earnings breakout/breakdown trigger

Past Performance

Axon's last 8 quarters: 2 consecutive beats.

BEAT
Q2 FY25
$2.12 vs $1.45 est - +16.4%
MISS
Q3 FY25
$1.17 vs $1.52 est - -9.4%
BEAT
Q4 FY25
$2.15 vs $1.60 est - +17.6%
BEAT
Q1 FY26
$1.61 vs $1.60 est - +10.6%

Q1 (May 6, 2026): EPS $1.61 vs $1.60 est[FMP], +0.6% beat. D+1 movement: +10.6%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $1.80 (no guidance)

Q1: EPS $1.61 vs $1.60 beat[FMP], stock +10.6% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $23.1M[FMP cashflow]. Q1 op margin 3.6%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $1.86 + CapEx discipline
Threshold: EPS > $1.86[FMP est].
Target: Break above median target $690[FMP target]; high target $820[FMP] upper bound.
Scenario B - In-Line
EPS approx $1.86 + CapEx < $23.1M
Threshold: EPS approx $1.86[FMP est], Q1 CapEx < $23.1M[FMP].
Target: Consolidation in the band between current $404[FMP] and median $690[FMP].
Scenario C - Miss
EPS < $1.80 or CapEx >= $23.1M
Threshold: EPS < $1.80[FMP estx0.97].
Target: Current $404 below SMA200 $593[FMP], if rejection continues, $504[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 10 analysts say?

Wall Street Consensus
$690
12-month median target price (+71.0% upside potential)
18
BUY
2
HOLD
0
SELL
Risk Management
$504
Invalidation level - critical support threshold
$446 - 50-day MA (below, -9.6%)
$593 - 200-day MA (below, -31.9%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - AXON Q1 FY27
B-

You read it in 5 minutes. When the numbers come out on Monday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Monday evening. The framework is ready on this page: Q1 EPS threshold $1.86[FMP], CapEx threshold "below $23.1M"[Brittany Bagley]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Aug 3, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Aug 4, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 17, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Nov 3, 2026EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the AXON earnings preview cover?

This AXON (AXON) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in AXON earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.